Stocks · Healthcare · Biotechnology
Opus Genetics, Inc. IRD
$4.58 +1.55% Close, Oct 2, 2026 · NASDAQ · Market cap $378.2M
Next earnings report: Nov 11, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin narrowed to -513.5% from -420.7% a year earlier.
- The diluted share count rose 75.8% in a year.
- Over the past year the stock returned +154.4%, ahead of the S&P 500 by 139.4 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 13%
- Revenue growth, 3-year CAGRBottom 6%
- Revenue growth accelerationBottom 11%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 21%
- Gross marginTop 4%
- Operating marginBottom 16%
- Accruals (lower is better)Top 3%
- Interest coverBottom 28%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 26%
- Free-cash-flow yieldBottom 36%
- EBITDA / enterprise valueBottom 20%
- Sales / enterprise valueBottom 15%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 10%
- 6-month returnBottom 44%
- 1-year return vs S&P 500Top 8%
- Distance from 52-week highBottom 46%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 23%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 11%
- Maximum drawdown, 3 yearsTop 24%
- Beta vs S&P 500 (lower is better)Top 19%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -12.2% | -36.1% | ↓ |
| Gross margin | 10.5% | 99.9% | ↑ |
| Operating margin | -420.7% | -513.5% | ↓ |
| FCF margin | -206.4% | -412.6% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -36.1% | -12.2% | ↓ | Bottom 13% |
| Gross margin | 99.9% | 10.5% | ↑ | Top 4% |
| Operating margin | -513.5% | -420.7% | ↓ | Bottom 16% |
| Net margin | -1091.8% | -377.9% | ↓ | — |
| Free-cash-flow margin | -412.6% | -206.4% | ↓ | — |
| Return on invested capital | -59.3% | — | Bottom 21% | |
| Revenue growth, 3-year CAGR | -29.1% | — | Bottom 6% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -72.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 45.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -32.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -19.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -10.46%
- Shareholder yield
- -10.46%
- Share count change, 1 year
- +75.8%
- Share count change, 3-year CAGR
- +74.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -0.9%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $12.60
- Target vs current price
- +175.1%
- Analysts with a rating
- 9
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +10.6% | -1.6% | -0.5% | +17.7% | — |
| May 12, 2026 | -368.7% | +1.2% | -13.3% | -20.3% | -27.3% |
| Mar 10, 2026 | -27.3% | +1.7% | +8.8% | +3.1% | -11.9% |
| Nov 12, 2025 | -78.6% | -2.5% | -4.6% | +26.9% | +71.6% |
| Aug 13, 2025 | +52.0% | -0.9% | +0.0% | +19.8% | +91.0% |
| May 15, 2025 | +29.4% | +0.0% | +7.4% | +4.4% | +11.6% |
| Mar 31, 2025 | -273.5% | -2.8% | -12.3% | -14.8% | -3.9% |
| Nov 12, 2024 | -20.8% | -2.6% | -22.1% | +2.6% | -2.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.14 | -$0.16 | +10.6% | $755,000 |
| May 12, 2026 | -$0.75 | -$0.16 | -368.7% | $2.2M |
| Mar 10, 2026 | -$0.14 | -$0.11 | -27.3% | $3.9M |
| Nov 12, 2025 | -$0.25 | -$0.14 | -78.6% | $3.1M |
| Aug 13, 2025 | -$0.12 | -$0.25 | +52.0% | $2.9M |
| May 15, 2025 | -$0.24 | -$0.34 | +29.4% | $4.4M |
| Mar 31, 2025 | -$1.27 | -$0.34 | -273.5% | $4.3M |
| Nov 12, 2024 | -$0.29 | -$0.24 | -20.8% | $3.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 32.90× | — | — | Bottom 15% |
| Free-cash-flow yield | -10.75% | — | — | Bottom 36% |
| Earnings yield | -27.73% | — | — | Bottom 26% |
P/E over the past five years
Range 1.0× – 1.7× since Dec 31, 2022. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 23
- Days above the 200-day average
- 23
- 50-day average slope (20 days)
- +15.7%
- 200-day average slope (20 days)
- +8.3%
- Distance from 50-day average
- +5.6%
- Distance from 200-day average
- +14.9%
- RSI (14)
- 45.8
- Relative volume
- 0.34×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 92.3%
- Volatility vs own 5-year history
- 92th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.56
- Correlation with S&P 500
- 0.10
- Current drawdown from 1-year high
- -24.5%
- Maximum drawdown, 3 years
- -51.1%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 8, 2025 | Apr 11, 2025 | -51.1% | 64 days | 109 days (Sep 18, 2025) |
| Apr 17, 2026 | Jul 23, 2026 | -49.2% | 66 days | 34 days (Sep 10, 2026) |
| Oct 28, 2024 | Dec 18, 2024 | -38.5% | 36 days | 10 days (Jan 3, 2025) |
| Sep 10, 2026 | Oct 1, 2026 | -25.7% | 15 days | Not yet recovered |
| Oct 31, 2025 | Nov 17, 2025 | -24.3% | 11 days | 15 days (Dec 9, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $378.2M
- EPS, diluted (TTM)
- -$1.27
- Revenue (TTM)
- $9.9M
- 52-week range
- $1.70 – $7.07
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $589,000 | $39.9M | $19.0M | $11.0M | $14.2M |
| Gross profit | $589,000 | $39.9M | $19.0M | $11.0M | $14.2M |
| Operating income | -$22.7M | $18.2M | -$10.6M | -$62.1M | -$38.6M |
| Net income | -$56.7M | $17.9M | -$10.0M | -$57.5M | -$49.6M |
| EPS (diluted) | -$3.82 | $0.87 | -$0.46 | -$2.15 | -$0.80 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M | $4.3M | $4.4M | $2.9M | $3.1M | $3.9M | $2.2M | $755,000 |
| Net income | -$7.5M | -$35.1M | -$8.2M | -$7.4M | -$17.5M | -$16.5M | -$65.5M | -$8.1M |
| EPS (diluted) | -$0.29 | -$1.11 | -$0.24 | -$0.12 | -$0.25 | -$0.19 | -$0.75 | -$0.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$19.4M | $14.3M | -$1.1M | -$25.6M | -$35.3M |
| Capital expenditure | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$19.4M | $14.3M | -$1.1M | -$25.6M | -$35.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $28.5M | $4.4M | $9.2M | $4.4M | $49.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $88.8M
- Total assets
- $93.0M
- Total liabilities
- $106.0M
- Total debt
- $34.9M
- Net debt
- -$53.9M
- Shareholders’ equity
- -$13.0M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 12,578,772
- Days to cover
- 1.51
- Change vs previous report
- +15.3%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Nov 6, 2020
- 1-for-4
- Apr 12, 2019
- 1-for-12
- May 5, 2017
- 1-for-10
- May 23, 2005
- 1-for-100